172 related articles for article (PubMed ID: 31953164)
1. Decreased secretion of tumor necrosis factor-α attenuates macrophages-induced insulin resistance in skeletal muscle.
Bu L; Cao X; Zhang Z; Wu H; Guo R; Ma M
Life Sci; 2020 Mar; 244():117304. PubMed ID: 31953164
[TBL] [Abstract][Full Text] [Related]
2. siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle.
Austin RL; Rune A; Bouzakri K; Zierath JR; Krook A
Diabetes; 2008 Aug; 57(8):2066-73. PubMed ID: 18443205
[TBL] [Abstract][Full Text] [Related]
3. Exposure to TNF-alpha but not IL-1beta impairs insulin-dependent phosphorylation of protein kinase B and p70S6k in mouse C2C12 myogenic cells.
Grzelkowska-Kowalczyk K; Wieteska-Skrzeczyńska W
Pol J Vet Sci; 2006; 9(1):1-10. PubMed ID: 16573269
[TBL] [Abstract][Full Text] [Related]
4. MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance.
Bouzakri K; Zierath JR
J Biol Chem; 2007 Mar; 282(11):7783-9. PubMed ID: 17227768
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake.
Storz P; Döppler H; Wernig A; Pfizenmaier K; Müller G
Eur J Biochem; 1999 Nov; 266(1):17-25. PubMed ID: 10542046
[TBL] [Abstract][Full Text] [Related]
6. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.
Remels AH; Gosker HR; Langen RC; Polkey M; Sliwinski P; Galdiz J; van den Borst B; Pansters NA; Schols AM
Biochim Biophys Acta; 2014 Feb; 1842(2):175-85. PubMed ID: 24215713
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV facilitates glucose transport in C2C12 myotubes through the IRS1/AKT pathway and suppresses the palmitate-induced activation of the IKK/IκBα pathway.
Zhu R; Zheng J; Chen L; Gu B; Huang S
Int J Mol Med; 2016 Jun; 37(6):1697-705. PubMed ID: 27082050
[TBL] [Abstract][Full Text] [Related]
8. GDF11 does not improve the palmitate induced insulin resistance in C2C12.
Jing YY; Li D; Wu F; Gong LL; Li R
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1795-1802. PubMed ID: 28485800
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells.
del Aguila LF; Claffey KP; Kirwan JP
Am J Physiol; 1999 May; 276(5):E849-55. PubMed ID: 10329978
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.
Lorenzo M; Fernández-Veledo S; Vila-Bedmar R; Garcia-Guerra L; De Alvaro C; Nieto-Vazquez I
J Anim Sci; 2008 Apr; 86(14 Suppl):E94-104. PubMed ID: 17940160
[TBL] [Abstract][Full Text] [Related]
11. The Baf60c/Deptor pathway links skeletal muscle inflammation to glucose homeostasis in obesity.
Meng ZX; Wang L; Xiao Y; Lin JD
Diabetes; 2014 May; 63(5):1533-45. PubMed ID: 24458360
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of TNF-α expression and inhibition of glucose uptake by nicotine in the presence of a free fatty acid in C2C12 skeletal myocytes.
Tatebe J; Morita T
Horm Metab Res; 2011 Jan; 43(1):11-6. PubMed ID: 21080305
[TBL] [Abstract][Full Text] [Related]
13. Tumor Necrosis Factor-α Promotes Phosphoinositide 3-Kinase Enhancer A and AMP-Activated Protein Kinase Interaction to Suppress Lipid Oxidation in Skeletal Muscle.
Tse MCL; Herlea-Pana O; Brobst D; Yang X; Wood J; Hu X; Liu Z; Lee CW; Zaw AM; Chow BKC; Ye K; Chan CB
Diabetes; 2017 Jul; 66(7):1858-1870. PubMed ID: 28404596
[TBL] [Abstract][Full Text] [Related]
14. Egg white hydrolysate and peptide reverse insulin resistance associated with tumor necrosis factor-α (TNF-α) stimulated mitogen-activated protein kinase (MAPK) pathway in skeletal muscle cells.
Son M; Wu J
Eur J Nutr; 2019 Aug; 58(5):1961-1969. PubMed ID: 29955954
[TBL] [Abstract][Full Text] [Related]
15. Conditioned medium from hypoxia-treated adipocytes renders muscle cells insulin resistant.
Yu J; Shi L; Wang H; Bilan PJ; Yao Z; Samaan MC; He Q; Klip A; Niu W
Eur J Cell Biol; 2011 Dec; 90(12):1000-15. PubMed ID: 21962636
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of insulin resistance by simvastatin in C2C12 myotubes and in mouse skeletal muscle.
Sanvee GM; Panajatovic MV; Bouitbir J; Krähenbühl S
Biochem Pharmacol; 2019 Jun; 164():23-33. PubMed ID: 30796916
[TBL] [Abstract][Full Text] [Related]
17. c-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-alpha induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists.
Fernández-Veledo S; Vila-Bedmar R; Nieto-Vazquez I; Lorenzo M
J Clin Endocrinol Metab; 2009 Sep; 94(9):3583-93. PubMed ID: 19567513
[TBL] [Abstract][Full Text] [Related]
18. Role of tumor suppressor PTEN in tumor necrosis factor alpha-induced inhibition of insulin signaling in murine skeletal muscle C2C12 cells.
Lo YT; Tzeng TF; Liu IM
Horm Metab Res; 2007 Mar; 39(3):173-8. PubMed ID: 17373630
[TBL] [Abstract][Full Text] [Related]
19. TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice.
Huang S; Ma S; Ning M; Yang W; Ye Y; Zhang L; Shen J; Leng Y
Metabolism; 2019 Oct; 99():45-56. PubMed ID: 31295453
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-106b induces mitochondrial dysfunction and insulin resistance in C2C12 myotubes by targeting mitofusin-2.
Zhang Y; Yang L; Gao YF; Fan ZM; Cai XY; Liu MY; Guo XR; Gao CL; Xia ZK
Mol Cell Endocrinol; 2013 Dec; 381(1-2):230-40. PubMed ID: 23954742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
